AGIO Agios Pharmaceuticals, Inc.
$33.60▼ -0.12%
Healthcare
Other
After hours
$32.93▼ -1.99%
Sep 11, 7:30 PM ET
Volume 750.2K
Avg Volume (10D) 788.7K
Key Metrics & Fundamentals
Market Cap
$2.01B
P/E Ratio
–
Div Yield
–%
52W Range
22.24 - 46.00
% vs 50 MA
-4.95%
% vs 200 MA
9.83%
RSI-14
48.3
MACD Histogram
+0.0800
Beta (1Y vs SPY)
0.55
Free Cash Flow
-$83.52M
Gross Rev
$44.75M
Gross Profit
$41.75M
EBITDA
-$109.20M
COGS
$3.00M
Operating Exp
$152.30M
Operating Income
-$110.55M
EBIT
-$110.55M
Pretax Income
-$100.70M
Net Income
-$100.70M
EPS (Diluted)
-1.69
Price & Volume History
Loading chart…
Recent News
Revolution Medicines (RVMD) Up 6.6% Since Last Earnings Report: Can It Continue?
Zacks · Sep 4, 2026 3:30 PM
AGIO Q2 Earnings Beat Estimates, Revenues Increase Year Over Year
Zacks · Jul 31, 2026 4:17 PM
Agios Pharmaceuticals Inc (AGIO) (Q2 2026) Earnings Call Highlights: Strong Mitapivat Revenue ...
GuruFocus.com · Jul 30, 2026 7:02 PM
Agios Pharmaceuticals Q2 Earnings Call Highlights
MarketBeat · Jul 30, 2026 2:04 PM
Agios Pharmaceuticals (AGIO) Reports Q2 Loss, Beats Revenue Estimates
Zacks · Jul 30, 2026 11:50 AM
Agios Pharmaceuticals Q2 Loss Narrows as Revenue Increases
MT Newswires · Jul 30, 2026 11:05 AM
Agios Pharmaceuticals: Q2 Earnings Snapshot
Associated Press · Jul 30, 2026 10:43 AM
Agios Reports Second Quarter 2026 Financial Results and Provides Business Update
GlobeNewswire · Jul 30, 2026 10:30 AM
Tebapivat Sickle Cell Setback and Mitapivat Priority Review Could Be A Game Changer For Agios (AGIO)
Simply Wall St. · Jul 30, 2026 12:14 AM
The Zacks Analyst Blog Highlights Harmony Biosciences, Acadia Pharmaceuticals, Biogen, Insmed and Agios Pharmaceuticals
Zacks · Jul 28, 2026 8:58 AM
Financial Overview - Income Statement
Quarterly
Jun 2026
See AGIO's money flow as a full page
Social Sentiment
No Reddit posts found for AGIO.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.